[Vitaprost plus in the treatment of chronic bacterial prostatitis].

Our study has demonstrated that compound medicine vitaprost plus in therapy of chronic bacterial prostatitis (CBP) reduces intensity of prostatic inflammation, significantly relieves symptoms of chronic prostatitis and pain syndrome. The absence of unwanted side effects, significant changes in clinical and biochemical blood and urine parameters evidences for good tolerance and safety of the drug. Thus, rectal suppositories vitaprost plus can be recommended for treatment of chronic bacterial prostatitis caused by both gram-positive and gram-negative bacteria in patients of different age and clinical symptoms.

[Administration of oral vitaprost for prevention of exacerbations of chronic abacterial prostatitis].

Active substance of vitaprost is a complex of water-soluble biologically active peptides isolated from bovine prostate. The prostatic extract has an organotropic action in relation to the prostate. As all peptide bioregulators, prostatic extract has antiaggregant and anticoagulant properties, enhances synthesis of antihistamine and antiserotonine antibodies, improves microcirculation in the prostatic gland. This accounts for its ability to reduce edema in prostatic inflammation. This clinical trial demonstrated that vitaprost tablets decreases twice probability of chronic prostatitis exacerbation, of development of secondary exacerbations. A prophylactic intake of vitaprost relieves symptoms of chronic prostatitis, first of all pain (discomfort), improvement of quality of life by NIH-CPSI, including exacerbation and significantly reduces size of the prostate. Vitaprost tablets can be effectively used prophylactively in chronic prostatitis for reducing probability of the disease exacerbations and their severity.

[Complex therapy of chronic bacterial prostatitis using matrix-urologist laser therapy].

A total of 49 patients with chronic bacterial prostatitis (CBP) were divided into two groups matched by age, the disease duration and severity of clinical symptoms. The study group consisted of 27 CBP patients who received antimicrobial therapy with sparfloxacine (fluoroquinolone of the third generation) and impact of vibromagnetolaser head of the VMLG-10 unit. The control group consisted of 22 CBP patients given antimicrobial therapy with sparfloxacine and 10 sessions of manual massage. Eradication of the bacteria was achieved in 25 (92%) patients of the study group and 19 (86.4%) patients of the control group. The treatment significantly attenuated the symptoms, normalized leukocyte count in the prostatic secretion, reduced size of the gland. Thus, application of the vibromagnetolaser head VMLG-10 of the laser therapy unit Matrix-urologist raises treatment efficacy in CBP patients.

[Ho-YAG laser endoscopic treatment of ureteral strictures]. / Endoskopicheskoe lechenie striktur mochetochnika gol'mievym lazerom.

Ho-YAG-laser radiation with wave length 2.09 microns is a perspective line in high-energy laser treatment of urinary diseases. The authors have performed 24 operations in 23 patients with ureteral strictures. The antegrade approach was used in 11 patients while the retrograde one in 12 cases. Primary or secondary strictures occurred in 8 and 15 patients, respectively. Dissection and ablation of the scar tissues were conducted in 15 patients with secondary strictures. Cut of the stricture only was made in 8 patients with primary strictures. Ho-YAG-laser endoscopic treatment of secondary and primary ureteral strictures reached 93.3%(14 patients) and 75%(6 patients), respectively. Overall efficacy was 88.2%(20 patients). Ho-YAG-laser endopyeloplasty promoted quicker recovery of urodynamic and functional parameters of the upper urinary tract.